<document id="DDI-DrugBank.d441">
    <sentence id="DDI-DrugBank.d441.s7" text="Patients who are treated with ZYVOX and concomitant serotonergic agents should be closely observed for signs and symptoms of serotonin syndrome (e.g., cognitive dysfunction, hyperpyrexia, hyperreflexia, incoordination).">
        <entity charOffset="30-34" id="DDI-DrugBank.d441.s7.e0" text="ZYVOX" type="brand" />
        <entity charOffset="52-70" id="DDI-DrugBank.d441.s7.e1" text="serotonergic agents" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d441.s7.e0" e2="DDI-DrugBank.d441.s7.e1" id="DDI-DrugBank.d441.s7.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d441.s8" text="If any signs or symptoms occur physicians should consider discontinuation of either one or both agents (ZYVOX or concomitant serotonergic agents).">
        <entity charOffset="104-108" id="DDI-DrugBank.d441.s8.e0" text="ZYVOX" type="brand" />
        <entity charOffset="125-143" id="DDI-DrugBank.d441.s8.e1" text="serotonergic agents" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d441.s8.e0" e2="DDI-DrugBank.d441.s8.e1" id="DDI-DrugBank.d441.s8.p0" type="advise" />
    </sentence>
    </document>